Gold (I) compounds and human neutrophil collagenase
Sorsa, T.; Konttinen, Y.T.; Lauhio, A.; Saari, H.; Suomalainen, K.; Lindy, S.
Journal of Rheumatology 16(7): 1009-1010
1989
ISSN/ISBN: 0315-162X PMID: 2549240 Document Number: 345017
Document emailed within 1 workday
Related Documents
Van Wart, H.E. 1992: Human neutrophil collagenase Matrix . Supplement 1: 31-36Tschesche, H.; Fedrowitz, J.; Kohnert, U.; Michaelis, J.; Macartney, H.W. 1986: Matrix degrading proteinases from human granulocytes: type I, II, IIi collagenase, gelatinase and type IV, V-collagenase. a survey of recent findings and inhibition by gamma-anticollagenase Folia Histochemica et Cytobiologica 24(2): 125-131
Ozaki, Y.; Ohashi, T.; Ohto, H.; Maeda, H. 1985: A monoclonal antibody against human neutrophil: evaluation of its effects on neutrophil function and partial characterization of the antigen Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 48(4): 980-991
Walz, D.T.; DiMartino, M.J.; Griswold, D.E. 1982: Comparative pharmacology and biological effects of different gold compounds Journal of Rheumatology. Suppl 8: 54-60
Miyamoto, S.; Inoue, T. 1992: Gold compounds and D-penicillamine for therapy of rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 50(3): 515-520
Gottlieb, N.L. 1979: Gold compounds in rheumatoid arthritis: clinical-pharmacokinetic correlates Journal of Rheumatology. Suppl 5: 51-55
Sadler, P.J. 1982: The comparative evaluation of the physical and chemical properties of gold compounds Journal of Rheumatology. Suppl 8: 71-78
Al Balla, S.; Johnston, C.; Davis, P. 1990: The in vivo effect of nonsteroidal anti-inflammatory drugs, gold sodium thiomalate and methotrexate on neutrophil superoxide radical generation Clinical and Experimental Rheumatology 8(1): 41-45
Hill, D.T.; Sutton, B.M.; Isab, A.A.; Razi, T.; Sadler, P.J.; Trooster, J.M.; Calis, G.H.M. 1983: Gold-195 Mössbauer studies of some gold(I) thiolates and their phosphine complexes including certain antiarthritic gold drugs Inorganic Chemistry 22(20): 2936-2942
Schultz, D.R.; Volanakis, J.E.; Arnold, P.I.; Gottlieb, N.L.; Sakai, K.; Stroud, R.M. 1974: Inactivation of C1 in rheumatoid synovial fluid, purfied C1 and C1 esterase, by gold compounds Clinical and Experimental Immunology 17(3): 395-406
Gondal, J.A.; Eiseman, J.L.; Alvares, A.P. 1987: Regulation of heme metabolism and monooxygeneses in liver and kidney: influence of therapeutically used gold compounds Journal of Pharmacology and Experimental Therapeutics 241(2): 540-546
Bruevich, T.S.; Bogomolets, N.N.; Berezovskiĭ, A.D. 1980: Sensitizing action of precious metal compounds: gold, platinum, ruthenium, rhodium and silver Gigiena Truda i Professional'nye Zabolevaniya (5): 42-44
Bauer, U. 1981: Human exposure to environmental chemicals - investigations on volatile organic halogenated compounds in water, air, food, and human tissues. IV. Communication: calculation of human exposure to organic halogenated compounds from the environment Zentralblatt für Bakteriologie Mikrobiologie und Hygiene. 1. Abt. Originale B Hygiene 174(6): 556-583
Mitchell, W.M. 1970: The contamination of purified collagenase preparations by clostridiopeptidase B (clostripain): the potential effect of studies utilizing collagenase as a highly specific structural tool Johns Hopkins Medical Journal 127(4): 192-198
Iida, M.; Doi, H.; Asamoto, S.; Sugiyama, H.; Sakagami, H.; Kuribayashi, N.; Takeda, M.; Okamura, Y.; Matsumoto, K. 1999: Effect of glutathione-modulating compounds on platinum compounds-induced cytotoxicity in human glioma cell lines Anticancer Research 19(6b): 5383-5384
Weisbart, R.H. 1992: An antibody that binds a neutrophil membrane protein, ERp72, primes human neutrophils for enhanced oxidative metabolism in response to formyl-methionyl-leucyl-phenylalanine. Implications for ERp72 in the signal transduction pathway for neutrophil priming Journal of Immunology 148(12): 3958-3963
Wojtecka-Lukasik, E.; Dancewicz, A.M. 1974: Human leucocyte collagenase isolation, purification and properties Przeglad Lekarski 31(4): 431-435
Clark, I.M.; Cawston, T.E. 1992: Fragments of human fibroblast collagenase: purification and characterisation Matrix . Suppl 1: 73
Rao, J.S.; Steck, P.A.; Mohanam, S.; Stetler-Stevenson, W.G.; Liotta, L.A.; Sawaya, R. 1993: Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors Cancer Research 53(10 Suppl): 2208-2211
Sorsa, T.; Uitto, V.J.; Suomalainen, K. 1992: Characteristics of human salivary collagenase and its relationship to periodontal diseases Matrix . Suppl 1: 406-407